Evaluation of an Organized Consultation "Return Home" of Patients With a Cancer (CREDO)

Institut Claudius Regaud

Status: Completed

Conditions: METASTATIC CANCER

Treatments: Other: CREDO standard of care; Other: current standard of care

Study type: Interventional

Funder types: Other

Identifiers

NCT02857400

16GENE11

Details and patient eligibility

About

Prospective, open label, randomized and multicentric study evaluating the efficacy of an organized consultation "return home" compared to a current standard of care in patient hospitalized due to metastatic solid tumor cancer.

Subject will be randomized (1:1) as described below :

• Arm A (standard) : current standard of care ; connection documentation faxed to GP ( General practitioner) on the day of patient's discharge Arm B (experimental) : CREDO standard of care, organized consultation "return home" between patient, GP DESC (diploma of complementary specialized study) and patient's referent GP

Enrollment: 667 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age > or = 18 years old
2. Subject hospitalized in an oncology dedicated center for administration of the first chemotherapy cycle.
3. Subject with metastatic solid tumor whatever the organ
4. subject planned to be discharged home after chemotherapy administration
5. Affiliated to the French social security system.
6. Subjects must provide written informed consent prior to any study-specific procedure or assessment

Exclusion criteria

1. Subject included in another trial evaluating the pathways care
2. Pregnant or breastfeedings women
3. Subject law protected

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

667 participants in 2 patient groups

Arm A (standard)

Other group

Treatment:

Other: current standard of care

Arm B (experimental)

Experimental group

Treatment:

Other: CREDO standard of care